L8684 Radiof trsmtr implt scrl neu

Radiofrequency transmitter (external) for use with implantable sacral root neurostimulator receiver for bowel and bladder management, replacement

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for L8684

DMEPOS fee schedule, July 2026 (DME26-C)

Payer policies and prior authorization for L8684

7 of 7 payer prior-auth lists that name L8684 require prior authorization or set conditions: Blue Cross Blue Shield of Arizona (AZ Blue), Blue Cross and Blue Shield of Illinois, Blue Cross and Blue Shield of New Mexico, Humana, Rocky Mountain Health Plans.

PayerPlanStatePrior authConditionsSinceSource
Blue Cross Blue Shield of Arizona (AZ Blue)AZ Blue-administered Medicare Advantage (M2K)AZprior auth requiredSep 1, 2026AZ Blue Medicare Advantage Prior Authorization Requirements Code List (Effective 09/01/2026)
Blue Cross Blue Shield of Arizona (AZ Blue)Standard PA code list (most commercial plans)AZprior auth requiredSep 1, 2026AZ Blue Standard Prior Authorization Requirements Code List (09/01/2026)
Blue Cross Blue Shield of Arizona (AZ Blue)State of Arizona employee group (SYD, S3Z)AZprior auth requiredSep 1, 2026State of Arizona Group Prior Authorization Requirements Code List (09/01/2026)
Blue Cross and Blue Shield of IllinoisBlue Cross Community MMAI (Medicare-Medicaid Alignment Initiative)ILprior auth requiredJan 1, 2025Procedure Code List, Effective 1/1/2025
Blue Cross and Blue Shield of New MexicoTurquoise Care (New Mexico Medicaid)NMprior auth requiredOct 1, 2026New Mexico Medicaid Benefit Preauthorization Procedure Code List 10/1/26
HumanaHumana Healthy HorizonsOKprior auth requiredJan 1, 2027Humana Healthy Horizons® in Oklahoma Prior Authorization Notification List (PAL) The following preauthorization and notification list
Rocky Mountain Health PlansRocky Mountain Medicare Advantage D-SNPCOprior auth requiredFeb 1, 2025Rocky Mountain Health Plans Medicare Advantage Dual-Special Needs Plans – prior authorization Effective February 1, 2025

Payer coverage policies that name L8684

L8684 appears in 18 coverage policies from Aetna, Anthem, Blue Cross & Blue Shield of Mississippi, Blue Shield of California, Capital Blue Cross, Centene, Premera Blue Cross, Regence.

PayerPolicyRole in policyReviewedDocument
AetnaDiabetic Neuropathy: Selected Treatments (0729)covered if criteria are metFeb 24, 2026payer document
AetnaFecal Incontinence (0611)
Acticon neosphincter
covered if criteria are metSep 23, 2026payer document
AetnaFunctional Electrical Stimulation and Neuromuscular Electrical Stimulation (0677)covered if criteria are metSep 10, 2026payer document
AetnaIntraoperative Neurophysiological Monitoring (0697)not covered (range L8679-L8689)Jun 19, 2026payer document
AetnaLevator Syndrome Treatments (0679)not coveredOct 15, 2025payer document
AetnaParkinson's Disease (0307)not coveredFeb 24, 2026payer document
AetnaSpinal Cord Stimulation (0194)covered if criteria are metSep 10, 2026payer document
AetnaUrinary Incontinence (0223)covered if criteria are metJul 16, 2026payer document
AnthemSacral Nerve Stimulation for Urinary Retention, Urinary Incontinence, and Fecal Incontinence (CG-SURG-95)covered if criteria are metAug 13, 2026payer document
Blue Cross & Blue Shield of MississippiSacral Nerve Neuromodulationstimulationcovered if criteria are metpayer document
Blue Shield of California| Occipital Nerve Stimulation (7.01.125)listed, no stancepayer document
Capital Blue CrossOccipital Nerve Stimulation (MP 2.372)
Procedure Codes
unproven / investigationalSep 1, 2026payer document
Capital Blue CrossSacral Nerve Neuromodulation-Stimulation (MP 1.033)
Procedure codes
covered if criteria are metMay 1, 2026payer document
CenteneFecal Incontinence Treatments (CP.MP.137)covered if criteria are metMay 1, 2026payer document
CenteneUrinary Incontinence Devices and Treatments Reference Number: CP.MP.142 (CP.MP.142)covered if criteria are metNov 1, 2025payer document
Premera Blue CrossSacral Nerve Neuromodulation/Stimulation (7.01.69)listed, no stanceJun 8, 2026payer document
Premera Blue CrossVagus Nerve Stimulation (7.01.593)
Page | 7 of 30 | ∞
listed, no stanceMar 23, 2026payer document
RegenceSacral Nerve Neuromodulation (Stimulation) for Pelvic Floor Dysfunction (Surgery 134)listed, no stanceOct 1, 2025payer document

Recent prior-auth changes

  • Apr 1, 2026: PA removed, Blue Cross and Blue Shield of Illinois
  • Apr 1, 2026: PA removed, Blue Cross and Blue Shield of Illinois
  • Mar 1, 2025: PA removed, Rocky Mountain Health Plans
  • Mar 1, 2025: PA removed, Rocky Mountain Health Plans

Medicaid fee-for-service

Prior authorization required or conditional in CO, IL, IN, NE, OH, VA.

  • AZ: $897.62 (dme), effective Oct 1, 2026
  • CO: $520.05 (chp_plus, non-facility), effective Jul 1, 2026
  • IL: $623.84 (dme), effective Jan 1, 2026
  • IN: $867.67 (professional, Advanced Practice Nurse (85%), non-facility), effective Jan 1, 2026
  • NE: $893.69 (dme), effective Jul 1, 2026
  • OH: $760.52 (dme), effective Jan 1, 2026
  • OK: $669.02 (dme), effective Jan 1, 2026
  • TX: $670.64 (dmepos_tos_9_e_j_l_and_r, Home Health Dme), effective Jan 1, 2008
  • VA: $837.69 (medical), effective Jan 1, 2024
  • VT: $698.78 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $602.37 (professional), effective Jan 1, 2021

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.